IL17A and coronary artery disorder: Compared to controls, patients with CAD had increased levels of interleukin (IL) 4, IL-9, IL-17, granulocyte-macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor alpha (TNF-⍺), interferon gamma (IFN-ɣ), platelet-derived growth factor-BB (PDGF-BB) with false discovery rate-adjusted p values < 0.050 (Table 2).